Bolden Therapeutics
PrivateLast Round
Pre Seed
Jan 17, 2024
Total Funding Raised
$2.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bolden Therapeutics is a biotechnology company that develops first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system illnesses such as Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bolden Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bolden Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 17, 2024 | ||||
| Grant | Sep 16, 2022 | ||||
| Grant | Jun 29, 2022 | ||||
| Grant | Sep 27, 2021 |
Bolden Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Resolute Venture Partners | Pre Seed |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| LifeSpan Vision Ventures | Pre Seed |
| Slater Technology Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 135% MoM, reaching 836.
- Mar 3, 2026
Monthly visitors grew 209% MoM, reaching 1.2K.
Bolden Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bolden Therapeutics's valuation, stock price, and market status.